At the time of the 5M guidance - it DID NOT include any new product launches for 2016 (so 3 products - last one coming in Nov is NOT INCLUDED)
It's probably only $250-300k in sales but they are not baked in. I am hoping the cross-sales of their other products, from the BH platform, are bigger than expected.
If Q3 hits or is better than I guarantee Q4 will be INCREDIBLE !! Alot riding on Q3 in terms of trajectory. No Premium at all by Mr. Market for Fluticare too IMO. That is just not factored in at all with current PPS
Market Data 
Markets 
AI
